Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase II study of Anti-PD-L1 Antibody MPDL-3280A(Atezolizumab) in combination with Gemcitabine/Cisplatin in patientswith locally advanced, unresectable, or metastatic biliary cancer
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Juneyoung Lee | - |
| dc.date.accessioned | 2021-08-28T19:48:46Z | - |
| dc.date.available | 2021-08-28T19:48:46Z | - |
| dc.date.created | 2021-04-22 | - |
| dc.date.issued | 2015-11-21 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/31216 | - |
| dc.publisher | 대한항암요법연구회 | - |
| dc.title | A phase II study of Anti-PD-L1 Antibody MPDL-3280A(Atezolizumab) in combination with Gemcitabine/Cisplatin in patientswith locally advanced, unresectable, or metastatic biliary cancer | - |
| dc.title.alternative | . | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Juneyoung Lee | - |
| dc.identifier.bibliographicCitation | The 10th KCSG Methodology Workshop | - |
| dc.relation.isPartOf | The 10th KCSG Methodology Workshop | - |
| dc.relation.isPartOf | The 10th KCSG Methodology Workshop booklet | - |
| dc.citation.title | The 10th KCSG Methodology Workshop | - |
| dc.citation.conferencePlace | KO | - |
| dc.citation.conferencePlace | 서울대학교 치과병원 제1,2 강의실 | - |
| dc.citation.conferenceDate | 2015-11-21 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 2 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.